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Abstract 
Introduction: Tuberculosis (TB) and Human immunodeficiency virus (HIV) co-infections 
are the leading cause of death in children globally, which accounts one-third of death 
among HIV positive children. However, there are limited studies that assess the survival 
status and predictors of mortality among TB/HIV co-infected children in Ethiopia. 
Objective: This study aimed to determine the survival rate and predictors of mortality 
among TB/HIV co-infected children enrolled at University of Gondar Comprehensive 
Specialized Hospital, Northwest Ethiopia from February 2005 to March 2017. 
Methods: A retrospective follow-up study was conducted. Data were extracted from the 
medical records of the children and entered into EPI-info version 7 then export to STATA 
version 12 for analysis. Log-rank test was used to compare the survival experience of two 
or more explanatory variables. A KaplanMeier curve was used to estimate the survival 
time. Bivariabe and multivariable Cox proportional hazards models were fitted to identify 
the predictors of time to death, with variables having a p-value<0.05 at 95%CI were 
considered as statistically significant. 
Result: Among a total of 271 TB/HIV co-infected children 38(14.02%) children were died 
during the follow-up period which gives 1167.67 child-years of observations. The overall 
mortality rate was 3.27(95%CI; 2.3, 4.5) per 100 child-years. The independent predictors 
of time to death were being age 1-5 years as compared with 1 year(AHR=0.3; 
95%CI=0.09-0.98)), being anemic  (AHR, 2.6;95%CI,1.24, 5.3), CPT non-users (AHR, 4.1; 
95%CI; 1.4, 16.75), IPT non-users (AHR, 2.95; 95%CI; 1.16, 7.5), having EPTB (AHR, 
2.43; 95%CI; 1.1, 5.3)) and fair or poor adherence (AHR, 3.5; 95%CI; 1.7, 7.5).  
Conclusion: Mortality rate among TB/HIV co-infected children at University of Gondar 
Comprehensive Specialized Hospital, Northwest Ethiopia was high. Age, extra 
pulmonary tuberculosis, anemia, adherence, CPT and IPT were Independent predictors 
of mortality. Therefore, those TB/HIV co-infected children, especially those with age less 
than one year,  extra pulmonary TB and anemia should be closely monitored to increase 
their ART adherence as well as they should be provided with CPT and IPT.   
 
Keywords: TB, HIV, TB/HIV co-infections, survival, mortality, Ethiopia.
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1. Introductions 
1.1. Statement of the problem 
Globally, Tuberculosis (TB) and Human immunodeficiency virus (HIV) co-
infections are the first leading cause of death among HIV-infected children (1). 
Tuberculosis remains a major public health problem especially after the era of HIV 
(2). It disproportionally affects those peoples living with HIV in low and middle-
income countries (2-4).  The World Health Organization (WHO)  2016 report 
estimated that there were 10.4 million new cases of TB globally (equivalent to an 
incidence rate of 142 cases per 100,000 population) and 1.4 million deaths due to 
TB in 2015 (5).  About 1.2 million cases of those TB cases occurred in HIV-positive 
peoples and 1.0 million occurred in children. The burden of TB/HIV co-infection is 
particularly high in developing countries, and approximately 74% of the global 
TB/HIV co-infection observed in sub-Saharan Africa (6). 
Ethiopia is one of the 30 high burden countries and has been classified as having 
high burdens of  TB and TB/HIV co-infection (5, 7) countries. The country is striving 
to reduce the magnitude of TB and HIV disease in line with the objectives of the 
sustainable development goal(SDG) (8). However, the problem still remains 
significant, particularly in children. Several studies had shown that the incidence 
of TB among HIV-positive children ranges from 1 to 9.9 per 100 PY.  TB is also 
mentioned as one of the top ten causes of death (9) and the most commonly 
reported opportunistic infection in children with HIV (10-13). In Ethiopia, it is a 
major cause of hospital admission and death especially in children with HIV (14), 
accounting for 26% of AIDS-related deaths (15). 
TB is a major public health problem in children, the diagnosis of TB in children, 
particularly in HIV-infected children, is generally challenging (16). Even though, 
there were advances in the implementation of prevention of mother to child 
transmission (PMTCT), careful scrutiny for TB exposure at every health care visit, 
with the provision of isoniazid preventive therapy (IPT) following each documented 
exposure event in HIV-infected children. In addition, to this, the management of 
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TB/HIV co-infection in children is very challenging especially in resource-limited 
counties like Ethiopia as a result of the unavailability of appropriate formulations of 
drugs, a drug to drug interactions, pill burden, drug side effects and other 
adherence issues (17). 
In 2015, 389,000 people die of globally due to TB/HIV co-infections, of those 
295,000 were in Africa. In children, 41,000 children were died due to TB/HIV co-
infections. Of them, 34,000 were lived in Africa (5). The mortality rate of TB/HIV 
co-infection was different in different setting and forms of TB which ranges from 
11% to 36.5% (18, 19). The reasons behind the mortality of TB/HIV co-infected 
children are multi-factorial (20). Which includes diagnosis age, nutritional status, 
immunity status, and hemoglobin levels at ART initiation (21). The identification of 
those predictors that determine the mortality rate of TB/HIV co-infected children 
should allow policy makers and health professionals to implement an integrated 
program aimed at enhancing the survival of children. This might be particularly 
important in resource-constrained settings and in high TB/HIV burden countries 
like Ethiopia to come up with better treatment strategies which will be crucial for 
TB/HIV co-infections. Hence, the aims of this study were to estimate the survival 
rate and to identify predictors of mortality among TB/HIV co-infected children at 
University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. 
 
 
 
 
 
 
    
pdfMachine - is a pdf writer that produces quality PDF files with ease! 
Get yours now!  
“Thank you very much! I can use Acrobat Distiller or the Acrobat PDFWriter but I consider your 
product a lot easier to use and much preferable to Adobe's" A.Sarras - USA  
 
Survival and predictors of mortality among TB/HIV co-infected children  
3 
 
1.2. Literature review 
1.2.1. Survival of TB/HIV co-infected children 
The survival of children co-infected with TB and HIV varies across the globe, as 
well as within countries, with socio-demographic and a number of other clinical risk 
factors being strong predictors of mortality (22, 23). 
A systematic review and meta-analysis conducted on TB/HIV co-infected children 
showed that the mortality rate of TB/HIV co-infected children was 11.4%  (24). A 
retrospective cohort study in Thailand showed that the survival rates at 1, 2, and 3 
years after TB diagnosis were 96.1%, 94.0%, and 87.7% among on ART user 
group and 44.4%, 19.2%, and 9.3% among non-ART user group respectively. 
Among patients on ART user group, the patients who delayed ART initiation ≥6 
months after TB diagnosis had a higher mortality rate than those who initiated ART 
<6 months after TB diagnosis (20). Another cohort study in Thailand also showed 
that the mortality of incident TB in HIV-infected children was 30% (21). 
A cohort study of children in India showed that the mortality rate were 17%, among 
TB/HIV co-infected children (25). Another similar study conducted in Indian 
children and adolescent with TB/HIV co-infection who had MDR-TB indicated that 
36.5% died of from MDR-TB/HIV co-infections (18). 
Similarly, another retrospective cohort study in South Africa showed that the 
mortality rate was 11% at 18 months after initiation of treatment (19).  A similar 
retrospective cohort study in South African children showed that the overall 
mortality rate of HIV-infected children with culture-confirmed tuberculosis was 
39.1% after completion of TB therapy. From these TB accounts 17.6 % of death (
26).  Similarly, a retrospective analysis at Durban, South Africa showed that the 
mortality rate among TB/HIV co-infected children was 17.5%(27). 
A retrospective cohort study conducted in Nigerian children showed that the 
survival rate of children with TB/HIV co-infection was 73.4% (28). 
Another retrospective cohort study conducted in Nigeria revealed that a mortality 
rate of children co-infected TB/HIV was 1.4 per 100 Child-Years (29). 
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1.2.2. Predictors of mortality in TB-HIV co-infected children 
Several predictors have been identified for the mortality of TB/HIV co-infected 
children in different countries and settings. A retrospective cohort study conducted 
in the United States of America showed that disseminated and Mengele TB, as 
well as the absence of TB treatment, were identified as predictors of death among 
TB/HIV co-infected children (30). 
A cohort study conducted in Thailand stated that gastrointestinal TB and multidrug-
resistant TB were associated with higher mortality rate. On the other hand, early 
initiation of ART within six months of TB diagnosis were associated with greater 
survival (20). 
A study in Indian children and adolescent showed that delayed initiation of ART or 
anti-TB, poor adherence to ART or anti-TB, and defaulted from treatment were the 
predictors of mortalities among the adolescents (18). 
A prospective cohort study conducted among TB/HIV co-infected children in 
Tanzania identified severe and moderate malnutrition, severe anemia, severe 
immunosuppression, history of tuberculosis, other opportunistic infections, living in 
an area with low socio-economic status, and advanced  WHO clinical stage was 
as predictors of mortality in HIV/TB co-infected children (31). A study in Nigerian 
children showed that children age less 1 year had lower survival rate, with only a 
survival rate of 29% (28). Another study conducted in Nigeria showed that 
malnutrition, IPT, delayed ART initiation and age less than 1 year at ART initiation 
were associated with death among TB/HIV co-infected children (32). 
A double-blind randomized control trail at Cape Town, South Africa on the effect 
of IPT on mortality showed that mortality was lower in the isoniazid group which 
was 8% than in the placebo group which was 16% (33). 
A retrospective cohort study in a regional TB referral hospital KwaZulu-Natal, 
South Africa, among children reported that mortality of TB/HIV co-infected children 
was determined by malnutrition, early initiation of TB treatment and severity of 
tuberculosis (19). A similar study in South Africa showed that early initiation of  
ART and expanding ART eligibilities were substantially decreased TB-related 
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mortality in children (34). Another prospective cohort study conducted in South 
African children showed that Malnutrition and severe radiographic findings were 
the predictors of death among TB/HIV co-infected children (19). Retrospective 
cohort study on South African HIV-infected children with culture-confirmed 
tuberculosis identified that severe malnutrition, age(<1 year),  negative tuberculin 
skin test,  HIV disease category and lack of cure at the end of TB therapy were 
significantly associated with overall mortality (26). A prospective study in South 
Africa showed that mortality was higher in HIV-1 infected children with tuberculosis 
than that of HIV-uninfected children and it was associated with late diagnosis and 
treatment of TB/HIV  co-infected children (35).  
A prospective cohort study conducted in Malawian children with TB-HIV co-
infection stated that severe immunosuppression and WHO Stage IV were 
significantly associated with mortality. Besides, not initiated on antiretroviral 
therapy (ART) at any time were 8.8 times more likely to die as compared to those 
initiated on ART 0-2 months after initiation of anti-tuberculosis treatment (36). 
A retrospective cohort study conducted among children diagnosed with TB in Addis 
Ababa, Ethiopia showed the survival of TB-HIV co-infected children are 
determined by malnutrition, early diagnosis of TB and adherence with TB treatment 
(37). 
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Conceptual framework 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Conceptual framework which shows the survival and predictors of 
mortality among TB/HIV co-infected children (source; literature review). 
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1.3. Justification of the study 
Tuberculosis and HIV co-infection is the leading cause of death among TB/HIV co- 
infected individuals may be because of their synergistic effects. 
In recent years, great efforts have been made to integrate tuberculosis diagnosis 
and treatment service into HIV care which is essential to prevent, diagnose and 
treat TB among people with HIV and HIV among TB patients. However, TB/HIV 
co-infection remains a major global and national health problem that requires 
substantial action to achieve the Sustainable Development Goals (SDG) and the 
END-TB strategies, which targeted to reduce TB death and incidence by 90% and 
80% respectively by 2030 compared with 2015. TB/HIV co-infection is especially 
common in children with age less than 15 years.    However, though there are 
limited studies regarding survival rate of TB/HIV co-infection in adult, data on the 
survival and predictors of TB/HIV co-infection in children are very limited, 
particularly in Northwest Ethiopia.  Therefore, this study will be important to guide 
an evidence-based clinical practice, to establish better treatment and preventions 
strategies in resource-limited settings such as Northwest Ethiopia by assessing 
the survival of TB/HIV co-infected children and by identifying the predictors of 
mortality among TB/HIV con-infected children. 
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2. Objectives 
2.1. General objective 
 To assess the survival rate and predictors of mortality among TB/HIV co-
infected children at University of Gondar Comprehensive Specialized 
Hospital, Northwest Ethiopia, from February 2005 to March 2017. 
2.2. Specific objectives 
 To estimate the survival rate of TB/HIV co-infected children at University of 
Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, from 
February 2005 to March2017. 
 To identify predictors of mortality among TB/HIV co-infected children at 
University of Gondar Comprehensive Specialized Hospital, Northwest 
Ethiopia, from February 2005 to March2017. 
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3. Methods 
3.1. Study design and period 
An institutional based retrospective follow-up study was conducted at University of 
Gondar Comprehensive Specialized Hospital pediatric ART clinic from 
February2005 to March 2017. 
3.2. Study area 
The study was conducted at University of Gondar Comprehensive Specialized 
Hospital ART clinic. It is located in North Gondar administrative zone, Amhara 
National Regional state, Ethiopia which is about 727 km Northwest of Addis Ababa 
(the capital city of Ethiopia). According to the 2007 population and housing census 
report, the total population size of Gondar town was estimated to be 206, 987. 
Currently, Gondar town has one public Comprehensive Specialized Hospital, one 
private general hospital, five government Health Centers and more than fifty 
private clinics. University of Gondar Comprehensive Specialized Hospital is a 
teaching Hospital which serves more than five million people of the North Gondar 
zone and peoples of the neighboring zones. The HIV care service of the Hospital 
was initiated in 2005 and has 7 outpatient rooms, one voluntary testing and 
counseling room, one pharmacy, and one laboratory. In the clinic 2 general 
practitioners, 2 Health Officer, 8 BSc nurses, 2 masters nurses, 2 masters of 
infectious disease and HIV medicine, and 20 supportive staff that means case 
managers and adherence supporters are working there.  Adult ART clinic, Pediatric 
ART clinic, VCT clinic and PMTCT clinic are the specialty clinics in the Hospital. 
Since 2005 in which the hospital started ART, 8581 adults and 1138 pediatrics 
patients are enrolled until March 2017. 
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3.3. Populations 
3.3.1. Source populations 
The source population was all TB/HIV co-infected children under 15 years age 
ever enrolled in pediatrics ART clinic at University of Gondar Comprehensive 
Specialized Hospital. 
3.3.2. Study populations 
The study population was those under 15 years old children with TB/HIV co-
infection who were registered on HIV care and support clinics from February 2005 
to March 2017. All TB/HIV co-infected children with age less than 15 years who 
were enrolled into ART program were followed from February 2005 to March 2017 
and followed from date of enrollment to the ART program to the date of the event 
(i.e. death) or date of the end of data collection (i.e. March 2017). 
3.3.3. Inclusion criteria 
All TB/HIV co-infected children age less than 15 years who were enrolled in 
Pediatric ART Clinic at University of Gondar Comprehensive Specialized Hospital 
from February 2005 to March 2017. 
3.3.4. Exclusion criteria 
Study participants with incomplete baseline information (i.e. CD4+ cell, WHO 
stage, Hgb level, Weight, Height, functional status/developmental milestone) were 
excluded. 
3.4. Sample size determination and sampling procedures 
The sample size was calculated using Epi info version-7 StatCalc software by 
assuming 95% CI, a power of 80%, mortality rate 6.2%  (29). Using these 
calculation 244 children were considered. However, since the numbers of TB/HIV 
co-infected children were small, all children who fulfill the inclusion criteria were 
included in the study. Medical record numbers of 565 childrens charts which had 
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TB screen positive were identified from the SMART care electronic database of 
University of Gondar Comprehensive Specialized Hospital ART clinic and 
retrieved. Finally, after carefully reviewed the chart page by page301 charts with a 
history of active TB were identified. Of these, 271 fulfill the inclusion criteria and 
were included in the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MRN=565 charts were 
retrieved which were TB screen 
positives   
301 who had history of active 
TB were identified   
271 
Included in the analysis    
 Some of them 
were lost  
 The rest were not 
have active TB 
30(9%) were excluded 
because of incomplete 
data 
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3.5. Study variables 
3.5.1. Dependent variable 
Time to death of children with TB/HIV co-infection 
3.5.2. Independent variables 
Socio-demographic characteristics: -child:-Age and sex. 
Care giver: - age, sex, residence, family size, relationship to the child, a child lives 
with, caregiver HIV status and mother HIV status. 
Baseline clinical characteristics: WHO clinical stage, CD4 count/percent, Hgb 
level, site of TB, Nutritional status and History of OI 
The follow-up, clinical and treatment-related characteristics: ART regimen, 
Adherence, IPT, CPT, Developmental milestone/Functional status, Nutritional 
status (Weight, Height). 
3.6. Operational definition 
Time to death: - the time from TB/HIV co-infection to the occurrence of the event 
(i.e. death) during the follow-up period. 
Events  The event of this study was death of a child. 
Censored  a child was considered as   censored if the child is lost to follow-up 
and transfer out to another service before developing the event or if the child alive 
until  the end of the study period that means up to March 2017. 
Loss to follow-up- children missing their appointment for follow up or drug pick 
up for more than three months 
Transferred out  those children who were transferred to other health care 
facilities 
Adherence to ART: was classified into good, fair, and poor according to the 
percentage of drug dosage calculated from the total monthly dose of ART drugs. 
Which describe as Good (equal to or greater than 95% or ≤ 3 doses missed per 
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month), Fair (85- 94% or 4-8 doses missed per month), or Poor (less than 85% or 
≥ 9 doses missed per month). 
Table1: WHO classifications of HIV-associated immunodeficiency in infants and 
children.  
Classification of HIV 
associated 
immunodeficiency 
Age-related CD4 values 
<11months 12-35months 36-59months >=5 years 
Non-significant >35 >30 >25 >500 
Mild 30-35 25-30 20-25 350-499 
Advanced 25-30 20-25 15-20 200-349 
Sever <25 <20 <15 <200 
 
3.7. Data collection tools and procedures 
After carefully observing the available information in the medical records of the 
children, appropriate data extraction tools were adapted in English from the 
national HIV intake and follow-up care Form. The data was collected by four nurses 
working in ART clinic who had ART training, by using the prepared data extraction 
tools from the children medical records such as pre-ART intake form, ART follow-
up form, and laboratory requests etc. Charts were retrieved from the SMART care 
database which was launched May 2015.   
3.8. Data quality control 
To maintain the quality of the data, data extraction tool were carefully adapted from 
the National follow-up care forms and the data was collected by staff nurses who 
had ART training and working in pediatric ART clinic who are very familiarize with 
the registration in the medical records of the children. One day training about the 
objectives, significance, and variables of the research, and how to extract the data 
by using the data extraction tools was given to four data collectors and two 
supervisors. The data extraction tool was pretested to check the consistency of the 
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data extraction tool from the same facilities in about 15 charts. Some charts were 
checked for completeness before the main data retrieval was started, to modify the 
data extraction tools based on the available variables. The data collection process 
was closely monitored by the principal investigator for completeness of the data. 
Completed questionnaires were checked regularly for completeness to identify the 
gaps and act immediately.   
3.9. Data processing and analysis 
After checking the data for completeness and consistency, it was entered into EPI-
info version 7 and then exported to STATA version 12 for cleaning, coding and 
analysis. In the meanwhile WHO Antro-Plus software was also used to classify 
indices variables or to assess the nutritional status of the child. Descriptive 
statistics were carried out and summarized using tables, chart and graph. Mortality 
rate was determined by using Child-Years of follow-up as a denominator for the 
entire cohort and for groups classified based on socio-demographic and clinical 
characteristics. Kaplan-Meier curve was used for analysis of probabilities of death. 
Log-rank test was used to compare survival curves between the different 
categories of the explanatory variables. A life table was used to estimate the 
probability of survival at a different time interval in the follow-up time. 
Both bivariable and multivariable Cox proportional hazard model were used to 
identify the predictors of time to death of TB/HIV co-infected children. Variables 
having p-value less than 0.2 in the bivariable analysis were fitted into the 
multivariable model. Ninety-five percent confidence interval of hazard ratio were 
computed and variables having a p-value less than 0.05 in the multivariable Cox 
proportional hazards model were considered as significantly associated with the 
dependent variable. The necessary assumption of Cox proportional hazard model 
was checked by using Schoenfield residuals test. 
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4. Ethical considerations 
Ethical clearance was obtained from the ethical review committee of the school of 
Nursing, University of Gondar. Permission letter was also obtained from University 
of Gondar Comprehensive Specialized Hospitals management and HIV care 
clinics focal person to use the secondary data for the purpose of this study. The 
name or any other identifying information was not been recorded on the 
questionnaire and all information is taken from the chart were kept strictly 
confidential and in a safe place. The questionnaires were kept with locked board 
and password protected computer was used for the storage to the data.  The 
information retrieved was used for only the study purpose. 
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5. Results 
5.1. Socio-demographic characteristics 
A total of 301 TB/HIV co-infected childrens charts were reviewed. Of these, 
30(9%) were excluded in the analysis due to missing data. Therefore, 271 TB/HIV 
co-infected children were included in the analysis. The mean age of the study 
participants was 6.6(±3.5 SD) years. Nearly one-fourth (27.7%) of the children 
were under 5 years of age and half of them (50.5%) were males. The majorities 
(80.81%) of the respondent were living in urban and 220 (81.18%) children were 
lives with their parents. Half (49.82) of childrens caregiver were between the age 
group of (25-34) years with a median age of 30 (IQR (27-38)) years. 
Approximately, two third (64.94%) of the childrens caregivers were HIV positive 
(Table 2).  
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Table 2:  Socio-demographic characteristics of TB/HIV co-infected children at 
University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 
from February, 2005 to March, 2017. (n=271). 
Characteristics 
Total N (%) Death N (%) Censored N (%) 
N=271 N=38 N=233 
Age (years) 
<1 year 11(4.06) 5(1.85) 6(2.21) 
1-5 year 77(28.41) 8(2.95) 69(25.46) 
6-10 year 125(46.13) 19(7.01) 106(39.11) 
11-14 years 58(21.40) 6(2.210 52(19.19) 
Sex 
Male 137(50.55) 19(7.01) 118(43.54) 
Female 134(49.45) 19(7.01) 115(42.44) 
Age of caregiver 
15-24 32(11.81 5(1.85) 27((9.96) 
25-34 135(49.82) 21(7.75) 114(42.07) 
35-44 68(25.09) 7(2.58) 61(22.51) 
>44 36(13.28) 5(1.85) 31(11.44) 
Residence  
Urban 219(80.81) 28(10.33) 191(70.48) 
Rural 52(19.19) 10(3.69) 42(15.5) 
Family size 
<=2 44(16.24) 10(3.69) 34(12.55) 
2-4 142(52.40) 18(6.64) 124(45.76) 
>=5 85(31.37) 10(3.69) 75(27.68) 
Caregiver of the child 
Parents 220(81.18) 31(11.4) 189(69.74) 
Siblings 19(7.01) 1(0.37) 18(6.64) 
Grand-parents 23(8.49) 3(1.11) 20(7.38) 
Others 9(3.32) 3(1.11) 6(2.21) 
Child lives with 
Parents 247(91.14) 34(12.55) 213(78.60) 
Orphaned 11(4.06) 2(0.74) 9(3.32) 
Others 13(4.80) 2(0.74) 11(4.06) 
Mother HIV status 
Positive 182(67.16) 22(8.12) 160(59.04) 
Negative 6(2.21) 2(0.74) 4(1.48) 
Unknown 83(30.63) 14(5.17) 69(25.46) 
Caregiver HIV status 
Positive 176(64.94) 22(8.12) 154(56.83) 
Negative 9(3.32) 3(1.11) 6(2.21) 
Unknown 86(31.73) 13 (4.80 ) 73(26.94) 
5.2. Clinical characteristics 
Of the total 271 children, 237(87.46%) of children had advanced baseline WHO 
stage (3 and 4). The eligibility criteria for initiation of HAART were mainly both 
CD4+ cell count or percent and WHO clinical stage 125(46%) followed by WHO 
clinical stage 104(38.38%). Ninety-five (35.06%) of children had experienced initial 
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regiment change during their follow-up time. Of this, 37(38.95%) were due to D4T 
phase out followed by Tuberculosis 33(34.74%). Twenty-eight (10.33%) children 
WHO were on ART had treatment failure. Of them, only 8(28.6%) were on second-
line ART.  
Forty-eight (17.7%) of the children were anemic at baseline with a median Hgb 
level 12 (IQR; 10.613). Regarding prophylaxis use, 236(87.45%) of the 
respondents were on co-trimoxazole Preventive Therapy (CPT), whereas, ninety-
seven (35.79%) were on isoniazid preventive therapy (IPT). At baseline stunting 
and underweight were 161(59.41%) and 194(71.59%) respectively (Table 3). 
Table3: Clinical characteristics of TB/HIV co-infected children at University of 
Gondar Comprehensive Specialized Hospital Northwest Ethiopia, from February 
2005 to March 20017. (n=271) 
Characteristics Total N (%) 
N=271 
Death N (%) 
N=38 
Censored N (%) 
N=233 
Baseline WHO stage I & II 34(12.55) 3(1.11) 31(11.4) 
III & IV 237(87.45) 35(12.9) 202(74.54) 
ART Eligibility criteria  CD4+ cell 37(13.65) 4(1.48) 33(12.8) 
WHO stage 104(38.38) 11(4.06) 93(34.32) 
Both  125(46.13) 23(8.49) 102(37.32) 
Not recorded  5(1.85) 0(0) 5(1.850 
Initial ART regiment 
based on NRTIs 
ABC-based 10(3.69) 5(1.85) 5(1.85) 
AZT-based  185(68.27) 20(7.38) 165(60.89) 
D4T-based 67(24.72) 12(4.43) 55(20.3) 
TDF-based 9(3.32) 1(0.37) 8(2.95) 
Initial ART regiments 
based on NNRTs 
EFV-based  102(37.64) 12(4.43) 90(33.21) 
NVP, PI and other 
based 
169(62.36) 26(9.59) 143(52.77) 
Initial regiment change  Yes  95(35.06) 13(4.8) 82(30.26) 
No  176(64.94) 25(9.23) 151(55.72) 
Reason for regiment 
change  
Side effect/toxicities   23(24.21) 6(6.32) 17(17.89) 
Treatment failure 2(2.11) 0 2(2.11) 
TB 33(34.74) 5(5.26) 28(29.47) 
Stock out 37(38.95) 2(2.11) 35(36.84) 
Treatment failure  Yes  28(10.33) 5(1.85) 23(8.49) 
No  243(89.67) 33(12.18) 210(77.49) 
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Characteristics  Total N (%) Death N (%) Censored N (%) 
Immunologic failure  Yes  20(7.38) 4(1.48) 16(5.9) 
No  251(92.62) 34(12.55) 217(80.07) 
Virologic failure  Yes  17(6.27) 3(1.11) 14(5.17) 
No  254(93.73) 35(12.92) 219(80.81) 
Clinical failure  Yes  5(1.85) 3(1.11) 2(0.74) 
No  266(98.15) 35(12.92) 233(85.24) 
Baseline HIV associated 
Immunosuppression  
status 
Non-significant/Mild 87(32.1) 8(2.95) 79(29.15) 
Advanced 73(26.95) 8(2.95) 65(23.99) 
Sever 111(40.96) 22(8.12) 89(32.84) 
Isoniazid Yes 97(35.79) 6(2.21) 91(33.58) 
No 174(64.21) 32(11.81) 142(52.40) 
Hemoglobing/dl <10 48(17.7) 14(5.17) 34(12.5) 
>=10 223(82.29) 24(8.86) 199(73.43) 
Co-trimoxazole 
preventive therapy 
Yes 236(87.08) 28(10.33) 208(76.75) 
No 35(12.92) 10(3.69) 25(9.23) 
Weight for age Normal 77(28.41) 12(4.43) 65(23.99) 
Underweight 194(71.59) 26(9.59) 168(61.99) 
Height for age Normal 110(40.59) 14(5.17) 96(35.42) 
Stunting 161(59.41) 24(8.86) 137(50.55) 
Adherence Good 231(85.24) 23(8.49) 208(76.75) 
Fair 27(9.96) 12(4.43) 15(5.53) 
Poor 13(4.8) 3(1.11) 10(3.69) 
Site of TB PTB 186(68.63) 13(4.80) 173(63.84) 
EPTB 85(31.37) 25(9.23) 60(22.14) 
Time at which TB is 
developed 
PRE ART 206(76.01) 25(9.23) 181(66.79) 
ART 65(23.99) 13(4.80) 52(19.19) 
Ninety-nine (53.51%), seventy-three (39.46%), and thirteen (7.03%) children 
greater than 5 years had a functional status of ambulatory, working, and bedridden 
respectively. Whereas, in children with age less than five years the developmental 
milestone were 48(54.55%), 37(42.05%) and 3(3.41%) for appropriate, delay and 
regression respectively. 
Among opportunistic infection that occurred at baseline diarrhea 30(22.4%), oral 
thrush 16(11.9%) and PCP 15(11.2%) contribute nearly half of the opportunistic 
infections (Figure 2). 
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Figure 2: History of opportunistic infections at baseline among TB/HIV co-infected 
children at University of Gondar Comprehensive Specialized Hospital, Northwest 
Ethiopia, from February 2005 to March 2017 
5.3. Mortality rate 
Two hundred seventy-one TB/HIV co-infected children were followed for different 
periods which give us 1167.67 Child-Years of observation. Study participants were 
followed for a minimum of 1 month and a maximum of 12 years, with a median 
follow-up period of 4(IQR; 1.9-6.5) years. A total of 38(14.02%) new deaths were 
observed. Hence, the overall mortality rate in this cohort was 3.27 (95%CI; 2.4, 
4.5) per 100 Child-Years at 95%CI. Among deaths observed during the follow-up 
period, exactly 50% were males. Twenty-five of them were extra pulmonary or/and 
disseminated tuberculosis and HIV co-infected and the rest 13 were pulmonary 
tuberculosis and HIV co-infected.  Twenty-three (60.5%) of deaths occurred within 
the first year of follow-up. 
The cumulative probability of survival at the end of 1 year was 91.2%, at the end 
of 3 years was 88.6%, at the end of 5 years was 85.8%, and at the end of 12 years 
was 79.4% respectively. On the other hand, the mortality rate in children less than 
1 year was very high (8.92 per 100 Child-Years) as compared with age greater 
than 1 year (2.99 per 100 Child-Years) (Table 4).  
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Table 4: Mortality rate stratified by selected socio-demographic and clinical 
characteristics of TB/HIV co-infected children at University of Gondar 
Comprehensive Specialized Hospital, from February 2005 to March 2017. 
Characteristics Total N 
(%) 
PY Death N 
(%) 
IDR 
Age (years) <1  11(4.06) 56.1 5(1.85) 8.92 
>=1  260(95.94) 1105.2 33(12.18) 2.99 
Residence  Urban 219(80.81) 1015.25 28(10.33) 2.76 
Rural 52(19.19) 152.4 10(3.69) 6.56 
Child lives with Parents 247(91.14) 1094.58 34(12.55) 3.1 
Orphaned 11(4.06) 36 2(0.74) 5.56 
Others 13(4.80) 37.1 2(0.74) 5.4 
Baseline WHO 
stage 
I & II 34(12.55) 114.25 3(1.11) 2.63 
III & IV 237(87.45) 1047 35(12.9) 3.34 
Baseline immunity 
status  
Non-
significant/Mild  
87(32.1) 337.83 8(2.95) 2.37 
Advanced/ 
severe  
184(67.9) 823.42 30(11.07) 3.64 
Initial ART 
regiment based 
on NRTIs 
ABC-based 10(3.69) 20.17 5(1.85) 24.8 
AZT-based  185(68.27) 828.33 20(7.38) 2.4 
D4T-based 67(24.72) 298.17 12(4.43) 4 
TDF-based 9(3.32) 20.99 1(0.37) 4.8 
Treatment failure  Yes  28(10.33) 149.58 5(1.85) 3.34 
No  243(89.67) 1018.1 33(12.18) 3.24 
Clinical failure  Yes  5(1.85) 12.67 3(1.11) 23.7 
No  266(98.15) 1155 35(12.92) 3 
Isoniazid Yes 97(35.79) 542 6(2.21) 1.1 
No 174(64.21) 625.66 32(11.81) 5.1 
Hemoglobin g/dl <10 48(17.7) 167.58 14(5.17) 8.4 
>=10 223(82.29) 1000.1 24(8.86) 2.4 
CPT Yes 236(87.08) 1079.58 28(10.33) 2.6 
No 35(12.92) 88.1 10(3.69) 11.4 
Adherence Good 231(85.24) 1037.92 23(8.49) 2.22 
Fair/poor 40(14.76) 123.33 15(5.54) 12.2 
Site of TB PTB 186(68.63) 801.67 13(4.80) 1.62 
EPTB 85(31.37) 365.999 25(9.23) 6.83 
Follow-up years  <1 44(16.24) 15.33 23(8.49) 150 
1-5 116(42.8) 345.92 9(3.32) 2.6 
>5 111(40.96) 800 6(2.21) 0.75 
    
pdfMachine - is a pdf writer that produces quality PDF files with ease! 
Get yours now!  
“Thank you very much! I can use Acrobat Distiller or the Acrobat PDFWriter but I consider your 
product a lot easier to use and much preferable to Adobe's" A.Sarras - USA  
 
Survival and predictors of mortality among TB/HIV co-infected children  
22 
 
5.4. Predictors of mortality 
Log rank (Mantel-Cox) test of equality of survival for the different categories of 
explanatory variables were done, and haemoglobin level at TB diagnosis, site of 
TB infection, CPT use, IPT use and adherence were significantly associated with 
time to death.  The mean survival time of the entire follow-up was 10.2(95%CI; 9.6, 
10.7) years among TB/HIV co-infected children. 
 
Figure 3:  Kaplan-Meier curve of survival proportion for TB/HIV co-infected children 
at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 
from February 2005 to March 20017. 
The mean survival time for those who had hemoglobin level less than 10 g/dl at 
TB diagnisis was 6(95%CI; 5, 7) years, but for those who had hemoglobin level 
greater than or equal to 10 g/dl was 10.6(95%CI; 10, 11) years and the difference 
was significant (p-value=0.0001)  
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Figure 4: Kaplan-Meier survival estimates of Hemoglobin level at TB diagnosis 
among TB/HIV co-infected children at University of Gondar Comprehensive 
Specialized Hospital, Northwest Ethiopia, from February 2005 to March 2017. 
The mean survival time of TB/HIV co-infected children for CPT users was high 
10.5(95%CI; 9.9, 10.9) years, as compared to non-CPT users 6(95%CI; 4.5, 7.7) 
years (p-value=0.0004).  
 
Figure 5: Kaplan-Meier survival curve of CPT use among TB/HIV co-infected 
children at University of Gondar Comprehensive Specialized Hospital, Northwest 
Ethiopia, from February 2005 to March 2017. 
The mean survival time of IPT users was high 11(95%CI; 10.5, 11.7) years as 
compared with IPT non-users 9.4(95%CI; 8.6, 10.2) years (p-value=0.001) 
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Figures 6: Kaplan-Meier survival cure of IPT use among TB/HIV co-infected 
children at University of Gondar Comprehensive Specialized Hospital, Northwest 
Ethiopia, from February 2005 to March 2017. 
The mean survival time of children co-infected with TB/HIV who had good 
adherence to ART drugs was high 10.6(95%CI; 10, 11.2) years as compared to 
fair or poor adherence 6.9(95%CI; 5, 8.5) years (p-value<0.0001). 
 
Figure 7: Kaplan-Meier survival curve of ART adherence level among TB/HIV co-
infected children at University of Gondar Comprehensive Specialized Hospital, 
Northwest Ethiopia, from February 2005 to March 2017. 
The mean survival time of children with extra-pulmonary TB was 10(95%CI; 9.5, 
10.4) years but it was 8.4(95%CI; 7.2, 9.5) years for those with pulmonary TB and 
the difference was significant (p-value<0.0001) 
Long-rank test p-value=0.001
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Figure 8: Kaplan-Meier survival cure of site of infection among TB/HIV co-infected 
children at University of Gondar Comprehensive Specialized Hospital, Northwest 
Ethiopia, from February 2005 to March 2017. 
Cox-regression analysis  
The bivariabe Coxregression analysis showed that age, Hemoglobin level, co-
trimoxazole preventive therapy (CPT), isoniazid prophylaxis (IPT), site of 
tuberculosis (TB), severe immunosuppression and adherence to ARV drugs were 
associated with the occurrence of death among TB/HIV co-infected children. 
However, in multivariable Cox-regression analysis age, CPT, IPT, site of TB, 
adherence to ARV drugs and hemoglobin level remained statistically significant 
predictors of death among TB/HIV co-infected children.  
According to our analysis, children whose age group (1-5) years were 70% at lower 
risk of death as compared with age <1 year (AHR 0.3(95%CI; 0.09-0.98)). Those 
children whose Hgb level< 10g/dl were 2.6 times at high risk to death as compared 
to that of Hgb level >=10g/dl (AHR=2.6, 95%CI=1.24-5.3). Similarly, HIV-positive 
children co-infected with extra-pulmonary or/and disseminated tuberculosis were 
2.43 times at high risk of death as compared with HIV-positive children co-infected 
with pulmonary tuberculosis (AHR=2.43; 95%CI 1.1-5.3). Children who didnt take 
CPT were 4.1times at high risk to die as compared with CPT users (AHR=4.1; 
95%CI=1.76-9.7). Similarly, children who were IPT non-users were 2.95 times at 
high risk for death as compared with IPT users (AHR=2.95; 95%CI=1.16-7.45). 
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A child with fair or poor adherence about ART drug was 3.57 times at high risk to 
death as compared with children who had good adherence to ART drugs. 
Table 5: Cox-regression analysis of predictors of time to death of TB/HIV co-
infected children at University of Gondar Comprehensive Specialized Hospital, 
Northwest Ethiopia, from February 2005 to March 2017. (n=271). 
Characteristics Death Censored CHR(95%CI) AHR(95%CI) 
Age <1year 5 6 1.00 1.00 
1-5 years 8 69 0.25 (0.082-0.77) 0.3(0.09-0.98) 
5-10 19 106 0.37(0.14-1.00) 0.7(0.22-2.3) 
10-14 6 52 0.29(0.09-0.96) 0.33(0.084-1.33) 
Mother HIV 
status 
Positive 22 160 1.00 1.00 
Negative/Unknown 16 73 1.77(0.93-3.37) 1.14(0.26-5) 
Address Urban 28 191 1.00 1.00 
Rural 10 42 1.99(0.96-4.11) 1.58(0.696-3.6) 
HIV status of 
caregiver 
Positive 22 154 1.00 1.00 
Negative /Unknown 16 79 1.57(0.82-2.997) 1.69(0.38-7.5) 
Immunity status 
at TB diagnosis 
N.S & mild 8 86 1.00 1.00 
Advanced IS 7 59 1.17(0.42-3.23) 1.3(0.44-3.94) 
Sever IS 23 88 2.32(1.04-5.199) 2.45(0.97-6.2) 
Hgb level at TB 
diagnosis 
<10 mg/dl 14 34 3.1(1.6-6) 2.6(1.24-5.3) 
>=10 mg/dl 24 199 1.00 1.00 
CPT Yes 28 208 1.00 1.00 
No 10 25 3.51(1.68-7.31) 4.1(1.76-9.7) 
IPT Yes 6 91 1.00 1.00 
No 32 142 3.87(1.6-9.28) 2.95(1.16-7.45) 
Site of TB PTB 13 173   
EPTB 25 60 4.43(2.26-8.67) 2.43(1.1-5.3) 
Adherence Good 23 208 1.00 1.00 
Fair/poor 15 25 4.86(2.5-9.3) 3.57(1.7-7.5) 
Time of TB 
occurrence  
Pre ART 25 181 1.00 1.00 
ART 13 52 1.68(0.86-3.29) 1.46(0.68-3.15) 
N.S= non-significant,   I.S= immunosuppression  
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6. Discussion 
Tuberculosis is the leading cause of death among children co-infected with TB and 
HIV (15). Hence, this study was aimed at determining the survival rate and 
predictors of mortality among TB/HIV co-infected children enrolled in pediatric HIV 
care clinic at University of Gondar Comprehensive Specialized Hospital. The 
overall mortality rate of TB/HIV co-infected children in this study was 
3.27(95%CI;2.4,4.5) per 100Child-Year of follow-up which was slightly higher than 
a cohort study conducted in Nigeria  which was 1.4(95% CI, 0.8,2.3)  per 100 Child-
Year follow-up) (29).This could be explained by the fact that, unlike this study, the 
previous one use only children co-infected with pulmonary tuberculosis and HIV. 
The other reason may be due to the difference in the follow-up period, in Nigeria 
study it was 5 years follow-up study. Whereas, our study is a 12 years follow-up 
study. The proportion of death in this study was 14%(95%CI;10,18)which was 
almost similar to a systematic review and meta-analysis conducted among TB/HIV 
co-infected children 11.4% (24), a retrospective analysis at Durban, South Africa 
17.5% (27), a cohort study conducted in Indian 17% (25), a retrospective cohort 
study conducted in South African HIV-infected children with culture-confirmed 
tuberculosis 17.6% (26), and a cohort study conducted in South Africa 11% (19). 
This fact might be explained by the similarity of TB burden in the general population 
in those countries, similarity in treatment, care and support strategy. The last but, 
not the least reason may be all the above-listed countries were high TB and TB/HIV 
burden countries (5, 7).However, the proportion of death in this study was lower 
than a cohort study conducted in Thailand incident TB/HIV co-infected children 
which were 30%(21), and similar study in Indian children and adolescent with 
TB/HIV co-infection which was 36.5% (18).This might be due to immune 
reconstitution inflammatory syndrome (IRIS) in Thailand, since most of the death 
were observed immediately after initiation of ART which increases the prevalence 
of IRIS(38).The other reason might be the difference in the quality of child care, 
study period and setting. The high mortality rate observed in Indian might be due 
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to the severity or category of TB, the study participant were co-infected with MDR-
TB and HIV, which might decrease the survival rate and increase the mortality rate. 
According to our analysis, the cumulative survival rate in this study was 79.4 %( 
95%CI; 71%, 85.6%) which is in line with a retrospective cohort study conducted 
in Nigeria 73% (28). This might be due to similarity in treatment protocol, socio-
demographic characteristics, and the similarity in the implementation of TB and 
HIV treatment, care and support service. The survival rate in our study at 1, 2 and 
3 years were 91.2%, 89.1% and 88.6% respectively, which were similar with a 
cohort study in Thailand 96.1%, 94% and 87.7% at 1, 2 and 3years respectively 
among ART users, and much higher than 44.4%, 19.2%, and 9.3% among non-
ART user group (20). The discrepancy in those of pre-ART may be due to the 
effect of ART drugs. Anti-retroviral drugs are responsible in viral suppression, 
which increase the CD4 cell, finally increase the survival of children and decrease 
risk of death which is supported, by study conducted in Malawi (36). 
In this study, highest mortality rate (8.92/100CY) was observed in the first year of 
follow-up. The pick mortality rate in the first year might be associated with the 
progression of sub-clinical disease that remains undetected during enrolment and 
progresses rapidly. Late arrival at health care means late diagnosis one predictor 
for death among TB/HIV co-infected children supported by study conducted in 
South Africa (35). The other fact could be Immune reconstitution inflammatory 
syndrome (IRIS) which is common within 6 months of ART initiation. The result 
also showed that a high number of children were started ART within the first year 
of follow-up which increases the probability of IRIS occurrence (38).The other 
possible reason for increased TB/HIV co-infected children survival with duration of 
follow-up could be the result of the progressive increase in CD4 cell count which 
builds the immune system and this may again decrease the viral load across time, 
finally increase the survival rate. 
In multivariable analysis, TB/HIV co-infected children age 1-5 years had 70% lower 
risk for death as compared with age less than 1 year(AHR 0.3 (95% CI; 0.09-0.98)) 
which is in agreements with the study conducted in South Africa(26), and Nigeria(
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32). The reason could be explained by the fact that, children with age less than 
one year had immature immune system especially in TB/HIV co-infected children 
who have the tendency to develop more severe disease. As a result, they become 
at high risk for death as compared with other age groups.  
Anemic children were 2.6 times at higher risk of death than non-anemic children, 
which were similar to the study conducted in Tanzanian (31), and Malawian (
36)TB/HIV co-infected children. This might be due to the effect of anemia on the 
oxygen intake capacity which had a synergistic effect with tuberculosis and HIV 
co-infections that increase the prognosis of the disease process which may end-
up with death.  
In the analysis predictors that were significantly associated with mortality rate were 
also co-trimoxazole preventive therapy non-users which had 4.1 times at high risk 
to die as compared with CPT users(AHR=4.1; 95%CI=1.76-9.7).Empirically, this 
could be due to the fact that the effect of CPT on decreasing most of the 
opportunistic infections including PCP.  Similarly, isoniazid preventive therapy non-
users had 2.95 times high risk to death as compared to non-users (AHR=2.95; 
95%CI=1.16-7.45), which was in line with a study conducted in Cape Town, South 
Africa(33) and Nigeria  (32). This could be due to the fact that isoniazid preventive 
therapy greatly reduces the recurrence of TB.  
Another important predictor of mortality was extra pulmonary or disseminated TB 
which had2.43 times at high risk of death than PTB (AHR=2.43; 95%CI=1.1-5.3). 
The result was similar to a cohort study conducted in United States of America and 
Thailand (20, 30). It is known that extra-pulmonary TB especially the disseminated 
one were more severe than pulmonary TB which increase the mortality rate. 
Lastly, this analysis indicated that children who had fair or poor adherence to ART 
drugs had 3.57 times at high risk for death as compared with children who had 
good adherence (AHR=3.57; 95%CI=1.7-7.5);Similar findings were reported in 
other studies conducted in Indian(18)and Addis Ababa Ethiopia(37). The reason 
behind might be when the child takes ART drugs adherently viral replication were
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suppressed which result increase in CD4 cells. Finally, increase the survival of 
children with TB/HIV co-infections. On the other hand, children who were unable 
to take ART drugs adherently had comeup with many problems such as treatment 
failure, a resistant strain which resulted in death the final outcome. 
7. Limitation and strength of the study 
The limitations of this study 
Since it was based on secondary data, there were data gaps due to incomplete 
medical records and poor linkage between ART and TB registers. Those study 
subjects whose chart was lost were not included in the study which may undermine 
the result if it is related to death. Due to diagnostic challenges, TB diagnosis was 
likely underestimated finally it may affect the outcome of the study. Charts were 
also lost when a patient admitted to the ward. These may also affect the study 
outcome.    
The strength of this study 
The study was conducted for a long follow up with a maximum follow-up of 12 
years period which enabled us to know the long-term impact of chronic HIV care 
and highly active antiretroviral therapy on survival of TB/HIV co-infection. The 
study was conducted during both Pre-ART and ART periods.  
 
8. Conclusion 
Mortality rate was high among TB/HIV co-infected children at University of 
Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.  Age, 
extra-pulmonary tuberculosis, anemia, fair or poor adherence, use of co-
trimoxazole preventive therapy, and isoniazid preventive therapy use were 
statistically significant predictors of mortality among TB/HIV co-infected 
children. 
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9. Recommendations 
1. To governmental and nongovernmental organizations;  
 Strengthening, encourage and promote the use of co-trimoxazole 
preventive therapy, and isoniazid preventive therapy. 
 Establish TB/HIV integrated care program at Chronic HIV care clinic to 
increase the adherences of children to the care. 
 Integrated TB/HIV treatment strategies need to be strengthened with early 
initiation of HAART as recommended in the national guideline. 
2. To Health care providers 
 Close follow-up for children co-infected with tuberculosis and HIV is 
important especially within the first year of enrollment to the chronic HIV 
care. 
 It would be better to give special attention for children age less than one 
year, anemia, fair or poor adherence and extra-pulmonary tuberculosis. 
 Children have to be screened for extra-pulmonary tuberculosis for early 
treatments initiation and follow up.  
 The adherences of the children should be closely monitored to provide all 
the necessary counseling about the importance of ART adherence. 
 It would be better to provide intensive counseling about ART drug 
adherence for the caregivers. 
3. For the child/caregivers;  
   Children have to take ART drugs adherently as prescribed by the 
health care providers. 
4. To Researchers;  
 The impact of late initiation of ART on the survival of TB/HIV co-infected 
children needed to be studied which was not included in this studies due 
to the incomplete data file.   
 Nationwide multi-center research on survival and predictors of mortality 
among TB/HIV co-infection children.  
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11. Annex 
Annex 1:  Information sheet 
The title of the Research Project: Survival and predictors of mortality among children 
co-infected with tuberculosis and human Immunodeficiency at University of Gondar 
Comprehensive Specialized Hospital, Northwest Ethiopia. A Retrospective cohort 
study 
Name of Investigator: KendalemAsmare (BSc in Nursing) 
Name of the Organization: University of Gondar College of Medicine and Health 
Sciences, school of Nursing. 
Name of the Sponsor: University of Gondar 
Introduction: this information sheet is prepared for University of Gondar Comprehensive 
Specialized Hospital Administration and Hospital HIV care clinic coordinating office. The 
aim of the form is to make the above-concerned office clear about the purpose of 
research, data collection procedures and get permission to conduct the research. 
The purpose of the Research Project: To assess the survival time and to identify 
Predictors of mortality among children co-infected TB and HIV in pediatrics HIV care clinic 
at University of Gondar Comprehensive Specialized Hospital. 
Procedure: In order to achieve the above objective, information which is necessary for 
the study will be taken from HIV care medical record follow-up forms, ART intake forms, 
and medical history sheet. 
Risk and /or Discomfort: Since the study will be conducted by taking appropriate 
information from medical chart, it will not inflict any harm on the patients. The name or 
any other identifying information will not be recorded on the questionnaire and all 
information is taken from the chart will be kept strictly confidential and in a safe place. 
The information extracted will be kept secured by locked intolocker by key. After the data 
will be interred into the computer by password. The information retrieved will only be used 
for the study purpose. 
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Benefits: the research had no direct benefit for those whose document/ record is included 
in this research. But the indirect benefit of the research for the participant and other clients 
in the program is clear. This is because if program planners are preparing predicted plan 
there is a benefit for clients in the program of getting appropriate care and treatment 
services for the children with TB/HIV co-infection. Of all, the research work has a 
paramount direct benefit for health care planners and managers, especially for those on 
HIV/TB collaborative program planning and management. 
Confidentiality: to reassure confidentiality the data on the cart will be collected by those 
individuals who are working on the HIV care clinic in the facility and information will be 
collected without the name of the clients. The information collected from this research 
project will be kept confidential and will be stored in a file. In addition, it will not be revealed 
to anyone except the investigator and it will be kept in key and locked system with 
computer pass ward. 
Person to contact: This research project will be reviewed and approved by the ethical 
committee of the school of nursing, College of Medicine and Health Science, University 
of Gondar. If you want to know more information, you can contact the committee through 
the address below. If you have any question you can contact the Investigator 
1. KendalemAsmare, University of Gondar, College of Medicine and Health Science, 
school of nursing: principal investigator 
 
Cell phone: +251- 09 18519124 
E-mail: kedasmar@gmail.com 
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የመረጃ እና ስምምነት ዉል ቅጽ  
የምርምሩ/ጥናቱ ርዕስ ፡  
በጎንደር ዩንቨርሲቲ ሪፈራል ሆስፒታል የኤች አይ ቪ ክትትል ባላቸዉ ህጻናት ላይ የሳንባ 
ነቀርሳ እና ኤች.አይ.ቪ አንድ ላይ ያለባቸዉ ሕጻናት ምን ያክል ይቆያሉ እና ተዛማጅ 
ምክንያቶችን በተመለከተ  
የዋና ተመራማሪ ስም ፡ ክንዳለም አስማረ  
የድርጅቱ ስም ፡- በጎንደር ዩኒቨርሲቲ ህክምናና ጤና ሳይንስ ኮሌጅ የነርሲንግ ትምህርት ቤት 
ወጭውን የሚሸፍነው አካል፡- ጎንደር ዩኒቨርሲቲ  
መግቢያ፡  
ይህ የመረጃ እና የስምምነት ዉል ቅጽ የተዘጋጀዉ ለጎንደር ዩንቨርሲቲ ሪፈራል ሆስፒታል 
አስተዳደር እንዲሁም በሆስፒታሉ ለሚገኘዉ የህጻናት ኤች አይ ቪ ክሊኒክ ክትትል ሀላፊ 
ነዉ። ዋና አላማዉም ስለ ምርምሩ ዓላማ ፤ ስለ መረጃ አሰባሰቡ ፤ እንዲሁም ጥናቱን 
ለማካሄድ ፍቃድ ለማግኘት ከላይ የተጠቀሱት አካላት ግልጽ እንዲሆንላቸዉ ለማድረግ ነዉ።  
ጥናቱ የሚካሄድበት ምክንያት፡  
የዚህ ጥናት ዋና አላማ በጎንደር ዩንቨርሲቲ ሪፈራል ሆስፒታል የኤች አይ ቪ ክትትል ባላቸዉ 
ሕጻናት ላይ የሳንባ ነቀርሳ እና ኤች.አይ.ቪ አንድ ላይ ያለባቸዉ ሕጻናት ምን ያክል ይቆያሉ 
እና ተዛማጅ ምክንያቶችን ለማጥናት ታቅዶ የተዘጋጀ ነዉ ።  
አተገባበር  
የጥናቱን አላማ ለማሳካት በጎንደር ዩንቨርሲቲ ሪፈራል ሆስፒታል የኤች አይ ቪ ክትትል 
ባላቸዉ የህጻናት ቻርት ላይ መረጃዉ ይሰመሰባል።  
ሊገጥም የሚችል ችግር /አለመመቸት  
የተወሰደዉ መረጃ ሙሉ በሙሉ ከቻርት ላይ ብቻ ስለሆነ በበሽተኞች ላይ ምንም አይነት 
ጉዳት አላመጣም። የቻርቱ ባለቤት ስምና መለያ ቁጥር ከመጠይቁ ላይ አልተገለጽም።  
የተሰበሰበዉ መረጃ በሎከር ተቆልፎ ተቀመጧል ወደ ኮምፒዉተር ከገባ በኋላ ድግሞ በሚስጥር 
ቁጥር ተቆልፏል፡፡ በተጨማሪም የተሰበሰበዉ መረጃ ለታቀደለት አላማ ብቻ ይዉላል ።   
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ጥቅሞች  
በዚህ ጥናት ተሳታፊ የሚሆኑ ሰዎች በቀጥታ ሊያገኙት የሚችሉት ጥቅም የለም ። ቢሆንም 
ግን መረጃዉ የኤች አይ ቪ እና ቲቢ  ያለባቸዉ ህጻናት ምን ያክል ጊዜ ይቆያሉ  እና ተዛማጅ 
ምክንያቶችን ለማጥናት ይጠቅማል። ከጥናቱ ዉጤት ተነስቶ በሚደረገዉ የፕሮግራም መሻሻል 
በቀጥታም ባይሆን ተጠቃሚ ይሆናሉ። በቀጥታ ሊጠቅም የሚችለዉ ግን በህጻናት ኤች.አይ.ቪ 
እና ቲቢ ዙሪያ ለሚሰሩ የጤና ባለሞያዎች እና ፕሮግራም አዉጭዎች ይሆናል፡፡ 
ሚስጥራዊነት  
ለዚህ ጥናት የሚሰበሰበዉን መረጃ ሚስጥር ለመጠበቅ ሲባል መረጃዉ የሚሰበሰበዉ 
በሆስፒታሉ ዉስጥ በሚገኘዉ የሕጻት ኤች አይ ቪ ክሊኒክ በሚሰሩ ነርሶች ነዉ ። ከዚህ በኋላ 
የተመረጡት ነርሶች በቻርቱ ላይ የሚገኘዉን መረጃ ይሰበስባሉ ። በሚሰበሰበዉ መረጃ ላይ 
የታካሚዉ ስም አይተቀስም፡፡የተሰበሰበዉ መረጃም ከጥናቱ ዋና ተመራማሪ እና ረዳቶቹ 
በስተቀር ለሌላ ለማንኛዉም ሰዉ ግልጽ አይሆንም ። የተገኘዉ መረጃም ለታቀደለት አላማም 
ብቻ ይዉላል።  
ሊያገኙት የሚችሉት ሰዉ 
የዚህ ምርምር ፕሮጀክት በጎንደር ዩንቨርሲቲ ህክምናና ጤና ሳይንስ ኮሌጅ የድርጅት ቁጥጥር 
ኮሚቴ ታይቶ የሚጸድቅ ይሆናል ። የትኛዉንም ዓይነት ጥያቄ መጠየቅ ቢፈልጉ ከዚህ ቀጥሉ 
የተጠቀሰዉን ግለሰብ ማግኘት እና በማንኛዉም ጊዜ መጠየቅ ይችላሉ ።  
1. ክንዳለም አስማረ ፡- ጎንደር ዩንቨርሲቲ ፤ነርሲንግ ትምህርት ቤት፤ዋና ተመራማሪ  
 
የሞባይል ስልክ +251-9 18519124  
ኢ-ሜል kedasmar@gmail.com 
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Annex 2: Data collection tool (questionnaire) 
Code No._________________________________ 
S. N. Part I: Socio demographic characteristics Skip to Qn 
 Child socio demographic characteristics  
101 Date of enrolment /                /                    /DD/MM/YY  
102 Age at enrolment Months/ year  
103 Sex 1. Male                               2. Female  
104 Birth order __________  
105 Mother HIV status  1. Positive 2, Negative   3. Unknown   
106 Child lives with  1. Parent 2. Guardian 3, Orphan 4. Others   
 Care giver socio demographic characteristics 
107 Age __________  
108 Sex 1. Male   2. Female  
109 Relationship to the child 1.  Mother 2. Father 3. Step parents 
4. Sibling   5. Others (specify)_______ 
 
110 Address 1. Urban         2.  Rural          3. Not recorded  
111 Family size __________  
112 HIV status of care giver  1. Positive 2, Negative   3. Unknown If 2 or 3 skip 
to 201 
113 If positive, is he/she in HIV care? 1. Yes         2. No  
 Part II: base line clinical characteristics 
201 WHO clinical stage 1. I   2. II    3. III   4. IV  
202 CD4+ count/percent _______(_____%)  
203 Hgb level __________mg/dl  
205 Weight at base line (_______)kg  
206 Height/length at baseline (------------)cm  
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207 History of OI 1, No   2, CMV    3, PCP  4,Herpes simplex    5,Kaposi 
sarcoma  6,Toxoplasmosis   7,Encephalopathy   
8,Wasting syndrome  9,Herpes   10,zoster                       
11,PGL   12, PML    13,  EPTB   14 , Candidiasis                   
15,Diarrhe  16,Pneumonia 
17 ,Other specify------- 
 
 Part III: HIV  care/ ART follow up 
301 Date confirmed HIV+ /                /                (DD/MM/YY)  
302 ART Eligible date /                /                 (DD/MM/YY)  
303 Eligible criteria 1. CD4 cell count                 3. Both 
2. WHO clinical stage           4. Not recorded 
 
 
304 Date ART started /               /                    (DD/MM/YY)  
305 Initial Regimen ______________________  
306 Was the Regimen changed? 1. Yes                       2. No If 2 310 
307 When was it changed /           /           (DD/MM/YY) & month -----  
108 New regiment ________________  
309 Reason for regimen change 1. Side effects        2. Treatment failure 3. TB 
4. Stock out    5. Others  
 
310 Did the child had treatment failure 1. Yes          2. No If 2 skip to 
314 
311 If yes when? ________  
312 Type of failure 1. Immunologic 2, virologic 3. clinical  
313 Second line regiment 1. _________  
314 OI prophylaxis 1. Not given     2. Co-trimoxazole    3. INH                4. 
Fluconazole    5. Others specify--------------- 
 
315 Adherence within 3 month of ART 
initiation  
1. Good   2. Fair   3. Poor   
316 Functional status for age greater than 
5 years within 3 months 
1. Working 2. Ambulatory   3. Bedridden   
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317 Developmental milestone for age <5 
years within 3 months 
1. Appropriate   2. Delayed 3. Regression   
Part IV: Tuberculosis related questions  
401  Time of TB occurrence  1. Pre ART   2. ART  
402 Site of TB infection  1. Pulmonary   2. Extra pulmonary  
403 WHO stage at TB diagnosis  1. III      2. IV  
404 CD4+ cells  ____________(__________%)  
405 Hemoglobin at TB diagnosis  ______________________  
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Part IV: Follow up form to be filled 
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If the patient Dead, drop out, transfer out or stop when was it occurs -------/------/-----DD/MM/YY? 
501 Final status  Death 2, Alive 3.Transfer out   
4. Loss to follow-up  
 
502 Final status date from enrolment (in month  ___________________  
503 Final status date from TB diagnosis (in 
moths  
______________________  
504 Periods at which final status occurred  Pre ART    2. ART  
Name of data collector -----------------------------sign ------------------date --------------------- 
Name of supervisor ____________________sign___________date _____________ 
 
    
pdfMachine - is a pdf writer that produces quality PDF files with ease! 
Get yours now!  
“Thank you very much! I can use Acrobat Distiller or the Acrobat PDFWriter but I consider your 
product a lot easier to use and much preferable to Adobe's" A.Sarras - USA  
 
Survival and predictors of mortality among TB/HIV co-infected children  
44 
 
 
Annex 3: Declaration 
I, the undersigned, MSc student declare that this thesis report is my original work in 
fulfillment of the requirement for the degree of Master of Science in advanced clinical 
pediatric and child health nursing. 
Name: Kendalem Asmare 
Signature: ______________ 
 
Place of submission: School of Nursing, College of Medicine and Health Sciences, 
University of Gondar. 
 
Date of Submission: ____________________________ 
This dissertation thesis report has been submitted for examine bored with my/ our 
approval as university advisor(s). 
Advisors 
Name                                                                             Signature 
1. Nigusie Birhan (BSc, MPH)            ______________ 
2. Daniel Tekle  (BSc, MSc)             ____________ 
 
 
    
pdfMachine - is a pdf writer that produces quality PDF files with ease! 
Get yours now!  
“Thank you very much! I can use Acrobat Distiller or the Acrobat PDFWriter but I consider your 
product a lot easier to use and much preferable to Adobe's" A.Sarras - USA  
 
